Pharmaterials Ltd The Queen's Awards for Enterprise 2008
Home
Company Locations
Careers
Initiate a Project
Contact Us
Request A Brochure
Search Our Site
Home | COMPANY    |     SCREENING    |     FORMULATION DEVELOPMENT    |     CONSULTANCY    |     GMP MANUFACTURE    |     PHYS PROPS    |     INHALATION SERVICES    |    
Screening
Polymorph Screening Amorphous Content Screening Pharmaceutical Co-crystals Crystallisation of amorphous material Salt screening / salt selection Developability screen Formulation screen Pharmaceutical Quality by Design (QbD)

Pharmaceutical Developability Screen

A key issue in taking a new active pharmaceutical ingredient into full development is to ensure that it will be suitable for pharmaceutical development.

Key issues in development are:

  1. Chemical stability
  2. Solubility / dissolution rate
  3. Processability (melting point / compressibility)

To ensure that the form is optimised we will assess the best form (salt or co-crystal) and make suggestions about the crystallinity, complexity, stability, dissolution and processing challenges for your active.

When taken in connection with our formulation screen you will rapidly be in a position to begin your development process with confidence.

First class information and advice - FAST.

  Home  |  Company  |  Screening  |  Formulation Development  |  Consultancy  |  GMP manufacture  |  Phys Props  |  Inhalation services  |  News  |  Site Map
© 2009 Pharmaterials Ltd, All rights reserved.       Site by : UKWebCo.com